Get started
Author

Darryl G. Turner

Cutting Edge: IL-6–Dependent Autoimmune Disease: Dendritic Cells as a Sufficient, but Transient, Source
2012 · Melanie D Leech, Tom A Barr, et al. · The Journal of Immunology · 49
PDF
Characterization of a galectin-like activity from the parasitic nematode, Haemonchus contortus, which modulates ovine eosinophil migration in vitro
2007 · D.G. Turner, L.A. Wildblood, et al. · Veterinary Immunology and Immunopathology · 49
T-bet Expression by Foxp3+ T Regulatory Cells is Not Essential for Their Suppressive Function in CNS Autoimmune Disease or Colitis
2015 · Rhoanne C. McPherson, Darryl G. Turner, et al. · Frontiers in Immunology · 38
PDF
Production of eosinophil chemoattractant activity by ovine gastrointestinal nematodes
2005 · Louise A. Wildblood, Karen Kerr, et al. · Veterinary Immunology and Immunopathology · 37
TLR-4 ligation of dendritic cells is sufficient to drive pathogenic T cell function in experimental autoimmune encephalomyelitis
2012 · Richard J Mellanby, Helen Cambrook, et al. · Journal of Neuroinflammation · 25
PDF
Eliminating roles for T-bet and IL-2 but revealing superior activation and proliferation as mechanisms underpinning dominance of regulatory T cells in tumors
2015 · Emily J. Colbeck, James P. Hindley, et al. · Oncotarget · 16
PDF
A novel lipidic peptide with potential to promote balanced effector-regulatory T cell responses
2022 · Michael Agrez, Justyna Rzepecka, et al. · Scientific Reports · 10
PDF
Exposure to inflammatory cytokines selectively limits GM ‐ CSF production by induced T regulatory cells
2014 · Ben C. Reynolds, Darryl G. Turner, et al. · European Journal of Immunology · 9
PDF
An immunomodulating peptide to counteract solar radiation-induced immunosuppression and DNA damage
2023 · Michael Agrez, Mark Stephen Rybchyn, et al. · Scientific Reports · 5
PDF
Abstract 5586: Demonstrating restoration of T cell function in exhausted T cells with IKZF3 small molecule inhibitor, Lenalidomide
2022 · Joanne Hay, Francis Acklam, et al. · Cancer Research · 5
An immunomodulating peptide with potential to suppress tumour growth and autoimmunity
2023 · Michael Agrez, Christopher Chandler, et al. · Scientific Reports · 4
PDF
Optimization of Cyclophilin B-Targeted Tri-vector Inhibitors for Novel MASH Treatments
2025 · Maria-Eleni Kouridaki, Jonathan Gillespie, et al. · Journal of Medicinal Chemistry · 3
Abstract 668: The translational biology of small molecule GPR65 inhibitors: shared effects between mouse models and human primary tumors highlight the unique transformative potential of targeting a genetically validated innate immune checkpoint
2023 · Barbara Cipriani, Alastair Corbin, et al. · Cancer Research · 3
Methods for Ex Vivo Analysis of Immune Cell Function from the Central Nervous System
2015 · Darryl G. Turner, Melanie D. Leech, et al. · Methods in molecular biology · 3
An Immunomodulating Peptide with Potential to Promote Anticancer Immunity Without Compromising Immune Tolerance
2025 · Michael Agrez, Christopher Chandler, et al. · Biomedicines · 2
PDF
1324 Inhibition of acid sensing by GPR65 normalises gene expression in macrophages, increases immune cell infiltration in tumors, and restrains subcutaneous MC38 growth in mice
2022 · Alastair Corbin, Stuart Hughes, et al. · Regular and Young Investigator Award Abstracts · 2
PDF
Abstract 3877: MPL-5821, a macrophage targeted ESMTM p38 MAPK inhibitor, inhibits the production of TLR agonist induced IL-10 whilst sparing T-cell functionality
2018 · David Moffat, Martin Perry, et al. · Cancer Research · 2
497 PTT-4256 is a first-in-class small molecule inhibitor of GPR65 that counteracts the low pH-dependent immunosuppressive effects on immune cells and displays pronounced anti-tumor activity in mice
2023 · Alastair Corbin, Barbara Cipriani, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
A novel immunomodulating peptide with potential to complement oligodeoxynucleotide-mediated adjuvanticity in vaccination strategies
2024 · Michael Agrez, Christopher Chandler, et al. · Scientific Reports
PDF
1012 Priming of tumor spheroids with IFN-gamma increases efficacy of T cell mediated killing with PD-1 blockade
2024 · Darryl Turner, Mary McBride, et al. · Regular and Young Investigator Award Abstracts
Abstract A122: Deciphering macrophage targeting cancer immunotherapies using a novel in vitro assay modelling the tumor microenvironment
2023 · Darryl Turner, Ross Dobie, et al. · Molecular Cancer Therapeutics
1504 Epithelial to mesenchymal transition (EMT) can be driven by macrophages through multiple signalling pathways
2023 · Darryl Turner, Ross Dobie, et al. · Regular and Young Investigator Award Abstracts
PDF
1046 Targeting novel pathways in chronically activated T Cells prevents functional exhaustion
2022 · Justyna Rzepecka, Andrew Hall, et al. · Regular and Young Investigator Award Abstracts
Abstract 419: The development of BRPF1 degraders as a potential treatment for acute myeloid leukemia
2022 · Daniel Joseph Glynn, Rosie Crampton, et al. · Cancer Research
251 The use of small molecule inhibitors to target novel pathways in exhausted T cells for immuno-oncology therapeutic intervention
2021 · Francis Acklam, Joanne Hay, et al. · Regular and Young Investigator Award Abstracts
PDF
Works count: 26
Citation count: 263
H-index: 8
I10-index: 7
Year
Topic
Type